Cytotoxic Activity of Echinomycin in a Human Tumor Cloning System
The DOI matches its Crossref record.
Abstract
A human tumor cloning system was utilized to screen for in vitro antitumor effects of the investigational anticancer agent Echinomycin. Tumors from 562 patients (24 different histological tumor types) were placed in culture. Two hundred fifty-five specimens were evaluable for drug sensitivity information (i.e., greater than or equal to 20 colonies in control plates). The overall in vitro response rates (defined as less than 50% survival of tumor colony-forming units) at three different doses of Echinomycin (0.001, 0.01, and 0.1 micrograms/ml) were between 16% and 19%. Echinomycin showed minor in vitro cytotoxic activity in breast and colon cancer, and in sarcoma. A comparison of these in vitro results with the results of phase-II clinical trials, as they become available, will help to evaluate the utility of the human tumor cloning system for predicting clinical antitumor activity of new antineoplastics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Echinomycin: The first bifunctional intercalating agent in clinical trials
Foster, B. J., Clagett-Carr, K., Shoemaker, D. D., Suffness, M., Plowman, J., Trissel, L. A., Grieshaber, C. K., & Leyland-Jones, B. (1985) · Investigational New Drugs · doi:10.1007/bf00170766 · Cited by 61
Gradishar, W. J., Vogelzang, N. J., Kilton, L. J., Leibach, S. J., Rademaker, A. W., French, S., & Benson, A. B. (1995) · Investigational New Drugs · doi:10.1007/bf00872868 · Cited by 49
“The drug also demonstrated cytotoxic activity, in vitro, against primary human tumor colony-forming units (breast, sarcoma, colon) [5].”
BackgroundPhase II trial of echinomycin in patients with advanced or recurrent colorectal cancer
Wadler, S., Tenteromano, L., Cazenave, L., Sparano, J. A., Greenwald, E. S., Rozenblit, A., Kaleya, R., & Wiernik, P. H. (1994) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00685088 · Cited by 43
Schilsky, R. L., Faraggi, D., Korzun, A., Vogelzang, N., Ellerton, J., Wood, W., & Henderson, I. C. (1991) · Investigational New Drugs · doi:10.1007/bf00176982 · Cited by 21
“In the human tumor stem cell assay, the drug demonstrated a 24% response rate for breast cancer, 25% for colorectal cancer and 38070 for sarcoma [6].”
BackgroundShevrin, D. H., Lad, T. E., Guinan, P., Kilton, L. J., Greenburg, A., Johnson, P., Blough, R. R., & Hoyer, H. (1994) · Investigational New Drugs · doi:10.1007/bf00873239 · Cited by 17
Metadata
- Authors
- LATHAN, B., & VON HOFF, D. D.
- Venue
- Cancer Drug Delivery
- Publisher
- SAGE Publications
- Published
- 1984-01
- Volume
- 1
- Issue
- 3
- Pages
- 191-198
- ISSN
- 0732-9482 (ISSN-L)
- OpenAlex
- W2013059926
- Cited by
- 14
- References
- 0
- FWCI
- 0.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cytotoxic Activity of Echinomycin in a Human Tumor Cloning System. https://app.cochat.ai/papers/10.1089/cdd.1984.1.191
- The paper
- LATHAN, B., & VON HOFF, D. D. (1984). Cytotoxic Activity of Echinomycin in a Human Tumor Cloning System. Cancer Drug Delivery. https://doi.org/10.1089/cdd.1984.1.191
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.